Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73
+1.431.47%
Post-market: 98.69-0.0465-0.05%19:30 EDT
Volume:7K
Turnover:644.33K
Market Cap:406.77M
PE:55.06
High:98.82
Open:97.68
Low:97.68
Close:97.30
52wk High:98.82
52wk Low:67.56
Shares:4.12M
Float Shares:4.12M
Volume Ratio:0.28
T/O Rate:0.16%
Dividend:1.55
Dividend Rate:1.57%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.64
PE(LYR):5.29

Loading ...

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Stock News
·
Aug 11

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610

THOMSON REUTERS
·
Aug 11

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals jumps 7% after rival's drug trial fails to meet key goals

Stock News
·
Aug 10

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-10

Reuters
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS
·
Aug 10

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Reuters
·
Aug 10

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS
·
Aug 10

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

TIPRANKS
·
Aug 08

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Reuters
·
Aug 08

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Reuters
·
Aug 08

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08